Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Anti-MDA5-like ulcerated Gottron's papules in anti-NXP2 dermatomyositis.
Journal: Clinical rheumatology
Published: September 28, 2025
Surgical Disease Burden, Outcomes, and Roles of Non-Physician Clinicians in Ugandan Emergency Departments.
Journal: The western journal of emergency medicine
Published: June 27, 2024
Response to "Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae"; Focus on griseofulvin.
Journal: Journal of the American Academy of Dermatology
Published: May 18, 2024
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study.
Journal: medRxiv : the preprint server for health sciences
Published: September 11, 2023
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study.
Journal: Journal of the American Academy of Dermatology
Published: March 12, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study.
Journal: medRxiv : the preprint server for health sciences
Published: January 30, 2023
Geographic access to dermatologic care in urban underserved communities.
Journal: Journal of the American Academy of Dermatology
Published: September 26, 2022
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
Journal: Journal of the American Academy of Dermatology
Published: September 05, 2022
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study.
Journal: Journal for immunotherapy of cancer
Published: May 13, 2022
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
Journal: Journal of the American Academy of Dermatology
Published: May 09, 2022
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.
Journal: JAMA dermatology
Published: January 12, 2022
Last Updated: 09/26/2026